Our RESETTM clinical trials with CABA-201 (investigational CD19-CAR T cell therapy) in lupus, myositis, systemic sclerosis, myasthenia gravis, and pemphigus vulgaris are now recruiting.
- What is Cabaletta Bio, Inc.'s stock symbol?
Our stock is traded on the Nasdaq under the symbol CABA.
- When was Cabaletta Bio, Inc. incorporated?
April 2017
- When did Cabaletta Bio, Inc. become a public company?
October 25, 2019
- Where is Cabaletta Bio, Inc. located?
2929 Arch Street
Suite 600
Philadelphia, PA 19104- When is Cabaletta Bio, Inc.'s fiscal year end?
December 31st
- Who is Cabaletta Bio, Inc.'s transfer agent?
American Stock Transfer & Trust Company, LLC
6201 15th Avenue
Brooklyn, NY 11219
T: 718-921-8200 x4801
help@astfinancial.com
www.astfinancial.com